How do you approach studying the pharmacokinetics of a drug in patients with hepatic diseases?

Sample interview questions: How do you approach studying the pharmacokinetics of a drug in patients with hepatic diseases?

Sample answer:

  • Assess Liver Function:
    • Evaluate the degree of hepatic impairment using diagnostic tests such as liver function tests (LFTs), liver biopsy, or imaging studies.
    • Determine the Child-Pugh or MELD score to classify the severity of liver disease.
  • Consider Hepatic Metabolism Changes:
    • Investigate the drug’s metabolism pathways and identify if they involve hepatic enzymes or transporters.
    • Determine if the drug undergoes biotransformation, conjugation, or excretion in the liver.
  • Adjust Dosing Regimens:
    • Reduce the initial dose or dosing frequency based on the extent of hepatic impairment.
    • Monitor drug levels closely to ensure therapeutic efficacy and minimize adverse effects.
    • Consider alternative routes of administration (e.g., rectal, transdermal) to bypass hepatic metabolism.
    • Extend dosing intervals to allow for slower elimination.
  • Evaluate Drug-Drug Interactions:

Leave a Reply

Your email address will not be published. Required fields are marked *